Special Feature

User Panel

My Panel

My Panel

Bookmark Science Articles

Recent News
Bookmark / Share This Science Site

Knockdown of polypyrimidine tract-binding protein suppresses ovarian tumor cell growth and invasiveness in vitro.

Knockdown of polypyrimidine tract-binding protein suppresses ovarian tumor cell growth and invasiveness in vitro. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

  • Abstract Text of This Paper
  • Journal Published
  • MeSH Keywords of This Abstract
  • Chemicals and Substances Used in this Paper
  • Grants and Granting Agency of this Research
  • Database Accession Numbers Used in this Paper
  • Related Papers
  • Related Research Tags
  • Rate this Research Paper
  • Knockdown of polypyrimidine tract-binding protein suppresses ovarian tumor cell growth and invasiveness in vitro. Abstract Text:

    x heX He,m poolM Pool,k m darcyK M Darcy,s b limS B Lim,n auerspergN Auersperg,j s coonJ S Coon,w t beckW T Beck,

    Polypyrimidine tract-binding protein (PTB) is an RNA-binding protein with multiple functions in the regulation of RNA processing and IRES-mediated translation. We report here overexpression of PTB in a majority of epithelial ovarian tumors revealed by immunoblotting and tissue microarray (TMA) staining. By western blotting, we found that PTB was overexpressed in 17 out of 19 ovarian tumor specimens compared to their matched-normal tissues. By TMA staining, we found PTB expression in 38 out of 44 ovarian cancer cases but only in two out of nine normal adjacent tissues. PTB is also overexpressed in SV40 large T-antigen immortalized ovarian epithelial cells compared to normal human ovarian epithelial cells. Using doxycycline-inducible small interfering RNA technology, we found that knockdown of PTB expression in the ovarian tumor cell line A2780 substantially impaired tumor cell proliferation, anchorage-independent growth and in vitro invasiveness. These results suggest that overexpression of PTB is an important component of the multistep process of tumorigenesis, and might be required for the development and maintenance of epithelial ovarian tumors. Moreover, because of its novel role in tumor cell growth and invasiveness, shown here for the first time, PTB may be a novel therapeutic target in the treatment of ovarian cancer.

    Knockdown of polypyrimidine tract-binding protein suppresses ovarian tumor cell growth and invasiveness in vitro. Publishing Authors By Initials

    x heX He,m poolM Pool,km darcyKM Darcy,sb limSB Lim,n auerspergN Auersperg,js coonJS Coon,wt beckWT Beck,

    For similar investigative techniques: chemistry, analytical: microchip analytical procedures: microarray analysis: tissue array analysis research abstracts see: investigative techniques: chemistry, analytical: microchip analytical procedures: microarray analysis: tissue array analysis research

    PUBMED ID PMID:

    MEDLINE DATE:

    Knockdown of polypyrimidine tract-binding protein suppresses ovarian tumor cell growth and invasiveness in vitro. Journal Published:

    PUBLICATION TYPE: Research Support, Non-U.S. Gov

    Journal: Oncogene

    VOLUME: 26

    Page Numbers: 4961-8

    Journal Abbreviation: Oncogene

    ISSN: 0950-9232

    DAY: 19

    MONTH: 02

    YEAR: 2007

    Knockdown of polypyrimidine tract-binding protein suppresses ovarian tumor cell growth and invasiveness in vitro. Information

    Number of References:

    LANGUAGE: eng

    NlmUniqueID: 8711562

    Knockdown of polypyrimidine tract-binding protein suppresses ovarian tumor cell growth and invasiveness in vitro. Keywords Mesh Terms:

    KEYWORDS: Tissue Array Analysis

    MESH TERMS: metabolism

    Chemical & Substance for Abstract: Knockdown of polypyrimidine tract-binding protein suppresses ovarian tumor cell growth and invasiveness in vitro. Information

    Substance Name: Polypyrimidine Tract-Binding Protein

    Registry Number: 139076-35-0

    Grant and Affiliation Information for Knockdown of polypyrimidine tract-binding protein suppresses ovarian tumor cell growth and invasiveness in vitro.

    AFFILIATION: Gynecologic Oncology Group, Core Laboratory in Molecular Pharmacology, University of Illinois at Chicago, Chicago, IL 60612, USA.

    Country: England

    England Research PublicationEngland Research Publication

    AGENCY: United States NCRR

    GRANT: C06RR15482

    ACRONYM: RR

    MEDLINETA: Oncogene

    REFSOURCE:

    DATABASENAME:

    ACCESSION NUMBER:

    Number Hits: 0

    Knockdown of polypyrimidine tract-binding protein suppresses ovarian tumor cell growth and invasiveness in vitro Related Publications

     

    Molecular Station USER Menu

    Welcome to Molecular Station!

    You have to register before you can post on our forums or use our advanced features. Register Now! Its Free and Fast!

    Already registered? Login now below.

    User Name:

    Password:

    Already registered and Forgot your password? Click below to recover it.

    Recover Lost Password

    Join now - it's fast and free!

    Molecular Station is THE largest network of researchers, scientists and science lovers anywhere!

    Research Terms of Usage and Disclaimer
    Home
    Features

    Protocols

    DNA Forum

    Science Forum

    DNA Forum
    Biology Forum

    Science News


    [CaRP] XML error: Invalid document end at line 2

    For more click here:Science News